MPLT Earnings Maplight Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–6 of 6
| Q1 2026 | 2026-03-31 | -1.34 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -18.56 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -105.70 | 2025-12-04 | 10-Q |
| Q1 2026 | 2025-03-31 | -29.33 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -105.38 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -77.37 | 2025-12-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.